Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  liposomal cytarabine-daunorubicin CPX-351
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-4 of 4 for your search:
Start Over
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: 60 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLTR0310-301, NCT01696084
Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLTR0308-204, NCT00788892
Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLTR0308-205, NCT00822094
Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLTR0305-101, NCT00389428
Start Over